Physician profile
Bret Taback
NPI 1659455483
$1,752.93
in general payments reported to CMS, 2019-2025
17 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2021: $26.53 · 2022: $389 · 2023: $578 · 2024: $189 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879 · Consulting Fee: $170 · Entertainment: $47.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.98 |
| Consulting Fee | $170.00 |
| Entertainment | $47.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $416.90 | 2022-2025 | Savi Scout |
| Tactile Systems Technology INC | $297.16 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Smith+Nephew, INC. | $235.23 | 2022-2025 | Renasys Touch |
| Merck Sharp & Dohme LLC | $130.29 | 2019-2025 | Keytruda, Lynparza |
| Genentech USA, INC. | $124.98 | 2019-2024 | Phesgo |
| Novartis Pharmaceuticals Corporation | $83.47 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $83.30 | 2019-2023 | Libtayo |
| Bard Peripheral Vascular, INC. | $66.42 | 2023 | |
| Puma Biotechnology, INC. | $58.31 | 2024-2025 | |
| Integra Lifesciences Corporation | $55.58 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kub Technologies INC. | $47.43 | 2023 | Mozart |
| Axogen | $36.47 | 2022 | |
| Amgen INC. | $30.51 | 2019 | |
| Sun Pharmaceutical Industries INC. | $26.13 | 2023 | Odomzo |
| Dilon Technologies, INC. | $23.19 | 2023 | Hemoblast Bellows |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22.14 | 2023 | V-Loc 180 |
| Clinigen, INC. | $15.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Taback listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.